CorMedix
CRMD
NZ$19.53
Share price
-2.84%
Change (1 day)
146.30%
Change (1 year)
Categories
Revenue for CorMedix (CRMD)
Revenue in 2025 (TTM): NZ$0.14 Billion
According to CorMedix's latest financial reports the company's current revenue (TTM 
) is NZ$0.13 Billion. In 2024 the company made a revenue of NZ$77.08 Million an increase over the revenue in the year 2023 that were of N/A. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for CorMedix from 2009 to 2025
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2025 (TTM) | NZ$0.14 B | 86.34% |
| 2024 | NZ$77.08 M | |
| 2023 | N/A | -100% |
| 2022 | NZ$0.1 M | -63.15% |
| 2021 | NZ$0.27 M | -15.69% |
| 2020 | NZ$0.33 M | -21.17% |
| 2019 | NZ$0.42 M | -34.36% |
| 2018 | NZ$0.64 M | 38.18% |
| 2017 | NZ$0.46 M | 43.33% |
| 2016 | NZ$0.32 M | 5.38% |
| 2015 | NZ$0.3 M | 27.09% |
| 2014 | NZ$0.24 M | 9820.69% |
| 2013 | NZ$0 M | |
| 2012 | N/A | |
| 2011 | N/A | |
| 2010 | N/A | |
| 2009 | N/A |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 Becton Dickinson BDX | NZ$35.01 B | 25,176.84% | 🇺🇸 USA |
 Emergent BioSolutions
EBS | NZ$1.56 B | 1,026.90% | 🇺🇸 USA |
 Utah Medical Products UTMD | NZ$65.89 M | -52.43% | 🇺🇸 USA |